According to the recent research led by Future Market Insights, the global optical genome mapping market will attain a valuation of USD 167.0 million by the year 2024. Projections indicate a subsequent increase to USD 1.3 billion by 2034, demonstrating a significant growth trajectory. The expansion represents a CAGR of 23.5% during the forecast period.
| Attributes | Key Insights |
|---|---|
| Optical Genome Mapping Market Estimated Size in 2024 | USD 167.0 million |
| Projected Market Value in 2034 | USD 1.3 billion |
| Value-based CAGR from 2024 to 2034 | 23.5% |
The optical genome mapping market expanded at a whopping 28.0% CAGR between 2019 and 2023. The global market is achieving heights to grow at a moderate CAGR of 23.5% over the forecast period 2024 to 2034.
The market saw a steady growth during the historical period, owing to advances in optical genome mapping technologies. Adoption of optical genome mapping in clinical settings expanded, driven by the need for comprehensive genomic analysis for disease diagnosis, treatment selection, and monitoring.
Increasing investments in genomic research and the rise of precision medicine had accelerated the demand for advanced genomic analysis tools, including optical genome mapping platforms.
Regulatory approvals and guidelines for optical genome mapping technologies facilitated market penetration and adoption in healthcare systems. Adoption of optical genome mapping in agriculture will increase, enabling precision breeding, crop improvement, and genetic resource conservation.
Integration with machine learning, big data analytics and AI will enhance data analysis capabilities, enabling deeper insights into genomic data and accelerating research and discovery. Efforts to expand market presence in emerging economies and regions with growing healthcare infrastructure will drive global market penetration and revenue growth.
Growing investments in genomics research, biotechnology, and healthcare infrastructure will fuel innovation, product development, and market expansion in the optical genome mapping sector.
| Country | The United States |
|---|---|
| CAGR through 2034 | 23.8% |
The optical genome mapping market in the United States will expand at a CAGR of 23.8% through 2034. The country is home to leading academic institutions, research organizations, and biotechnology companies at the forefront of genomic research.
Ongoing advancements in genomic technologies, including optical genome mapping, drive research innovation and stimulate market growth.
The United States is at the forefront of adopting precision medicine approaches, which rely on comprehensive genomic analysis to tailor medical treatments. Optical genome mapping technologies play a crucial role in this paradigm shift by providing high resolution analysis of genomes.
| Country | The United Kingdom |
|---|---|
| CAGR through 2034 | 24.7% |
The optical genome mapping market in the United Kingdom to expand at a CAGR of 24.7% through 2034. The country is home to renowned academic and research institutions with expertise in genomics and molecular biology.
Collaboration between academia, industry, and healthcare providers fosters innovation, technology development, and translation of research findings.
The United Kingdom has made significant investments in genomic medicine initiatives, such as the 100,000 Genomes Project and the Genomics England program. Government support for genomic research and healthcare infrastructure drives the adoption of advanced genomic technologies like optical genome mapping.
| Country | China |
|---|---|
| CAGR through 2034 | 24.4% |
Optical genome mapping trends in China are taking a turn for the better. A 24.4% CAGR is forecast for the country from 2024 to 2034. The country has a rapidly growing biotechnology ecosystem with a strong focus on innovation and entrepreneurship.
Biotechnology start-ups and companies in China leverage government support, and access to capital to commercialize advanced genomic technologies.
China is investing in modernizing its healthcare infrastructure and implementing precision medicine initiatives. Integration of genomic technologies, including optical genome mapping, into clinical practice and healthcare delivery systems to fuel the market growth.
| Country | Japan |
|---|---|
| CAGR through 2034 | 25.4% |
The optical genome mapping market in Japan is poised to expand at a CAGR of 25.4% through 2034. The country provides research funding and support for genomic research and technology development.
Research grants, funding initiatives, and academic industry collaborations stimulate innovation, drive technology adoption. Japan actively collaborates with international partners in genomic research, healthcare, and industry.
Collaborative initiatives and partnerships enable knowledge exchange, technology transfer, and market expansion, driving growth opportunities.
| Country | Korea |
|---|---|
| CAGR through 2034 | 26.0% |
The optical genome mapping market in Korea will expand at a CAGR of 26.0% through 2034. The country has a high incidence of cancer and is actively engaged in cancer genomics research and precision oncology initiatives.
Optical genome mapping technologies enable comprehensive profiling of tumor genomes, identification of driver mutations, and characterization of tumor heterogeneity.
Korea has been an early adopter of next generation sequencing technologies for genomic research and clinical applications. Optical genome mapping complements NGS by providing high resolution structural variation analysis.
The below table highlights how instruments segment is leading the market in terms of component, and will account for a CAGR of 23.2% through 2034. Based on application, the research segment is gaining heights and will to account for a CAGR of 23.0% through 2034.
| Category | CAGR through 2034 |
|---|---|
| Instruments | 23.2% |
| Research | 23.0% |
Based on component, the instruments segment will dominate the optical genome mapping market. Increasing investments in genomic research and biotechnology drive the demand for instruments used in optical genome mapping.
Research institutions, academic laboratories, and biotechnology companies invest in advanced instruments to support their genomic research initiatives. The integration of optical genome mapping into clinical diagnostics drives demand for instruments suitable for use in healthcare settings.
Instruments capable of processing clinical samples, providing accurate and reliable results, and meeting regulatory requirements for diagnostic use are in high demand.
In terms of application, the research segment will dominate the optical genome mapping market. Optical genome mapping is particularly valuable for the analysis of complex genomes, including large and repetitive regions that are challenging to analyze using other genomic technologies.
Researchers studying complex organisms, such as plants, animals, and microorganisms, rely on optical genome mapping to unravel the complexities of their genomes. Optical genome mapping offers high resolution analysis of structural variations in genomes, such as insertions, deletions, duplications, and translocations.
There is a growing demand for optical genome mapping in structural variation analysis, with increasing recognition of the importance of structural variations in disease pathogenesis and population genetics.
The competitive landscape of the optical genome mapping market is dynamic and evolving, characterized by the presence of established players, emerging companies, and technological advancements driving innovation and market growth.
Company Portfolio
| Attribute | Details |
|---|---|
| Estimated Market Size in 2024 | USD 167.0 million |
| Projected Market Valuation in 2034 | USD 1.3 billion |
| Value-based CAGR 2024 to 2034 | 23.5% |
| Forecast Period | 2024 to 2034 |
| Historical Data Available for | 2019 to 2023 |
| Market Analysis | Value in USD Million |
| Key Regions Covered | North America; Latin America; Western Europe; Eastern Europe; South Asia and Pacific; East Asia; The Middle East & Africa |
| Key Market Segments Covered | Component, Application, Solution, End Use, Region |
| Key Countries Profiled | The United States, Canada, Brazil, Mexico, Germany, France, Spain, Italy, Russia, Poland, Czech Republic, Romania, India, Bangladesh, Australia, New Zealand, China, Japan, South Korea, GCC countries, South Africa, Israel |
| Key Companies Profiled | Bionano Genomics Inc.; Nucleome Informatics Private Limited; Nabsys Inc.; Praxis Genomics LLC; PerkinElmer Inc.; OpGen Inc.; SourceBio International Limited; MedGenome Labs Private Limited; Genohub Inc.; Cerba HealthCare |
The optical genome mapping market is projected to reach a valuation of USD 167.0 million in 2024.
The optical genome mapping industry is set to expand by a CAGR of 23.5% through 2034.
The optical genome mapping market is forecast to reach USD 1.3 billion by 2034.
Korea is set to be the top performing market, exhibiting a CAGR of 26.0% through 2034.
Instruments segment is preferred, and will account for a CAGR of 23.2% through 2034.
Explore Life Science & Biotechnology Insights
Optical Genome Mapping Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
